A Better Newspaper

Entity

PanRes – Unified Antimicrobial Resistance Database (2026)

PanRes is a curated antimicrobial resistance database of 11,717 genes integrating acquired and latent resistance determinants within a unified ontology, with 3D protein structural clustering enabling resistance detection across sequence-divergent proteins (bioRxiv, June 2026). It reportedly addresses fragmentation across existing AMR databases and may become a reference standard for genomic surveillance pipelines.

Importance: 62%Confidence: 70%Mentions: 1Updated: June 23, 2026
## PanRes – Unified Antimicrobial Resistance Database ### Overview PanRes is a curated genomic database integrating 11,717 genes covering acquired and latent determinants of antibiotic, biocide, and metal resistance within a unified ontology, according to a preprint published on bioRxiv (bioRxiv, June 2026). It reportedly addresses fragmentation across existing antimicrobial resistance (AMR) resources by consolidating determinants previously distributed across databases with differing scopes and annotation standards. ### Technical Architecture The database includes predicted representative protein structures clustered by structural similarity, grouping proteins into 598 structurally conserved clusters (bioRxiv, June 2026). Structure-guided alignments reportedly allow detection of resistance determinants despite significant sequence divergence — a capability not available in sequence-only databases. The inclusion of latent resistance determinants (intrinsic/chromosomal) alongside acquired resistance genes distinguishes PanRes from narrower resources such as CARD or ResFinder. ### Strategic Significance - **Genomic surveillance**: PanRes may become a reference standard for clinical and environmental AMR surveillance pipelines, with implications for regulatory submissions, diagnostic tool development, and public health policy. - **3D homology search**: The structural clustering approach positions PanRes as infrastructure for next-generation AMR detection tools, particularly as protein structure prediction (e.g., AlphaFold) becomes standard in life sciences workflows. - **Intellectual property**: The unified ontology and structural cluster methodology may carry IP implications for developers of AMR diagnostic platforms integrating or building upon the database. ### Status As of June 2026, PanRes is at preprint stage (bioRxiv, June 2026). Peer review, institutional adoption, and integration into clinical surveillance pipelines remain pending. The database's open or restricted access terms have not yet been publicly detailed. ### Connections - Antimicrobial resistance genomic surveillance policy - Protein structure prediction tools (AlphaFold ecosystem) - Regulatory frameworks for AMR diagnostics